GRAL GRAIL, Inc. - Common Stock
$74,73
Cena · Sie 20, 2026
Dane fundamentalne na dzień Sie 6, 2026
Zakres 52 tyg.
$30–$119
50% of range
Ocena Analityków
HOLD
15 analysts
Cena Docelowa
$72
P/E (TTM)
-6860.3
ROE
-16.7%
Marża Zysku Netto
-277.5%
O GRAIL, Inc. - Common Stock Przegląd firmy z Wikipedii
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
Czytaj więcej
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
In June 2021 GRAIL launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023 EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024.
Activities
Illumina's own research showed that repeatedly sequencing DNA in the bloodstream made it possible to detect floating bits of DNA from cancer cells more accurately. It initially aimed to recruit greater than 100,000 people into its clinical trials in order to accumulate the sizeable data required to detect and interpret cancer biomarkers.
Galleri test
As of November 2020 Galleri investigated three multi-cancer screening tests.
In June 2021 Galleri launched their liquid biopsy or multi-cancer early detection test (MCED), which Grail called the Galleri test. Grail promoted the test as a "groundbreaking and potentially life-saving advance", although the results of early trials were poor. A subsequent large-scale NHS England trial was described as overhyped and unethical. As of 2024, Grail was facing discontent and legal action from investors.
In June 2025, an article in the New Yorker discussed an interview of their medicine and science writer regarding the test and its recent history with a focus on its potential for adaptation as research continues in its product development through clinical investigations.
On 17 October 2025, BBC news carried positive coverage of test results just presented at the European Society for Medical Oncology. However, as of October 20, 2025 the results of the PATHFINDER 2 study have yet to be peer reviewed or published. Eric Topol reported a sensitivity of only 40% these false negatives failed to discover cancer that emerged during the 12-month follow-up.
Company history
Grail began as a San Francisco biotechnology and pharmaceutical startup company in 2015, the parent company being Illumina of San Diego, which produces most of the DNA sequencing machines that scientists use to study human biology and diagnose rare genetic diseases. Richard Klausner, then chief medical officer at Illumina and former director of the National Cancer Institute, advocated for the new business. According to the San Francisco Business Times, he correctly predicted how DNA sequencing technology would make it possible to detect evidence of a tumor from a blood sample. He also joined Grail's board of directors. According to Forbes in 2017, 20% of Grail's profits are kept by Illumina.
In September 2020, Illumina announced an agreement to purchase Grail outright for $7.1 billion.
On November 27, 2020, Grail announced a commercial partnership with the National Health Service (England) (NHS), to trial the Galleri test, reporting in 2026.
In March 2021, the Federal Trade Commission (FTC) sued to block the vertical merger. In September 2022, an administrative judge ruled against the FTC's position on antitrust grounds.
In June 2023, Grail disclosed that letters were mailed to 408 patients incorrectly informing them that they may have cancer. The company blamed the incident on PWNHealth, saying that it was due to a software configuration issue, not due to incorrect Galleri test results.
In October 2023, the European Commission ordered Grail to be divested from Illumina within the next twelve months. The European Commission (EC) has since approved Illumina's divestment plan for separating from Grail. Illumina has set a goal of finalizing the divestment terms by the end of the second quarter of 2024. In April 2024, the EC approved Illumina's plan, allowing Illumina to explore either a trade sale or a capital markets transaction (spin-off) to divest Grail. In May 2024, Illumina publicly filed a Form 10 registration statement with the U.S. SEC, a necessary step for a potential capital markets separation of Grail. If a capital markets transaction occurs, Illumina must capitalize Grail with around $1 billion to fund 2.5 years of operations per the EC's divestment plan. The spinoff was completed in June 2024, with Grail trading on the Nasdaq with ticker symbol GRAL and Illumina retaining a 14.5% share of Grail.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
GRAL Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$74.73
Kapitalizacja Rynkowa
$3.07T
P/E (TTM)
-6860.3
EPS (TTM)
$-11.11
Przychody (TTM)
$147M
Stopa dywidendy
—
ROE
-16.7%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$30 – $119
GRAL Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$147M
2023-01-01
→
2025-12-31
EPS
$-11.11
2023-01-01
→
2025-12-31
Wolny przepływ pieniężny
$-300M
2024-12-31
→
2025-12-31
Marże
-277.5%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
GRAL
Mediana porównawcza
P/E (TTM)
-6860.3
—
P/S (TTM)
20886.9
18.3
P/B
1192.5
3.3
Price / FCF (Cena / FCF)
-10249.4
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
GRAL
Mediana porównawcza
Operating Margin (Marża Operacyjna)
-382.0%
—
Net Profit Margin (Marża Zysku Netto)
-277.5%
-180.4%
ROA
-13.8%
-36.2%
ROE
-16.7%
-43.7%
ROIC
-16.7%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
GRAL
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
12.0
9.7
Quick Ratio (Wskaźnik Szybkości)
3.4
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
GRAL
Mediana porównawcza
Revenue YoY (Przychody R/R)
17.2%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
38.4%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
GRAL
Mediana porównawcza
GRAL Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
15 analityków
- Mocne kupno 4 26,7%
- Kup 5 33,3%
- Trzymaj 6 40,0%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
8 analityków · 2026-08-19
Mediana
$74.50
Teraz
$74.73
Niski
$60.00
Wysoki
$88.00
Średni cel
$74.50
-0,3%
Średnia cel
$72.38
-3,2%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.61%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-2.56 | $-2.71 | 0.15% |
| 31 marca 2026 | $-2.29 | $-2.82 | 0.53% |
| 31 grudnia 2025 | $-2.44 | $-2.76 | 0.32% |
| 30 września 2025 | $-2.46 | $-3.59 | 1.1% |
| 30 czerwca 2025 | $-3.18 | $-3.64 | 0.46% |
| 31 marca 2025 | $-3.10 | $-4.17 | 1.1% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | — |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | — |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | — |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | — |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | — |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | — |
| IRON | $3.01B | -13.2 | — | — | -31.3% | — |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 15
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $147M | $126M | $93M | |
| R&D Expense | $196M | $322M | $339M | |
| SG&A Expense | $159M | $214M | $200M | |
| Operating Expenses | $709M | $2.31B | $1.61B | |
| Operating Income | $-562M | $-2.19B | $-1.52B | |
| Interest Income | $29M | $27M | $8M | |
| Other Non-op | $-993.0K | $64.0K | $-208.0K | |
| Pretax Income | $-535M | $-2.16B | $-1.51B | |
| Income Tax | $-126M | $-135M | $-42M | |
| Net Income | $-408M | $-2.03B | $-1.47B | |
| EPS (Basic) | $-11.11 | $-63.54 | $-47.21 | |
| EPS (Diluted) | $-11.11 | $-63.54 | $-47.21 | |
| Shares (Basic) | 36,753,751 | 31,901,259 | 31,049,148 | |
| Shares (Diluted) | 36,753,751 | 31,901,259 | 31,049,148 | |
| EBITDA | $-562M | $-2.19B | · |
Bilans 25
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $250M | $214M | $97M | |
| Receivables | $18M | $20M | $17M | |
| Prepaid Expense | $15M | $17M | $20M | |
| Current Assets | $954M | $820M | $156M | |
| PP&E (Net) | $52M | $69M | $85M | |
| PP&E (Gross) | $122M | $123M | $121M | |
| Accum. Depreciation | $70M | $54M | $36M | |
| Goodwill | · | $0 | $889M | |
| Intangibles | $1.85B | $2.02B | $2.69B | |
| Other Non-current Assets | $7M | $8M | $8M | |
| Total Assets | $2.92B | $2.98B | $3.91B | |
| Accounts Payable | $2M | $5M | $20M | |
| Accrued Liabilities | $64M | $57M | $74M | |
| Current Liabilities | $80M | $77M | $164M | |
| Capital Leases | $43M | $55M | $70M | |
| Deferred Tax | $219M | $346M | $33M | |
| Other Non-current Liabilities | $3M | $2M | $1M | |
| Total Liabilities | $344M | $480M | $268M | |
| Common Stock | $40.0K | $34.0K | · | |
| Paid-in Capital | $12.79B | $12.31B | · | |
| Retained Earnings | $-10.21B | $-9.80B | $-7.78B | |
| AOCI | $3M | $1M | $1M | |
| Stockholders' Equity | $2.58B | $2.50B | · | |
| Liabilities + Equity | $2.92B | $2.98B | $3.91B | |
| Shares Outstanding | 40,331,360 | 33,893,409,000 | 0 |
Przepływy pieniężne 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $58M | $86M | $97M | |
| Deferred Tax | $-126M | $-134M | $-38M | |
| Amort. of Intangibles | $134M | $134M | $134M | |
| Operating Cash Flow | $-299M | $-577M | $-596M | |
| CapEx | $909.0K | $5M | $13M | |
| Investing Cash Flow | $-85M | $-551M | $-13M | |
| Financing Cash Flow | $423M | $1.24B | $464M | |
| Net Change in Cash | $39M | $116M | $-145M | |
| Taxes Paid | $1M | · | · | |
| Free Cash Flow | $-300M | $-582M | · |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -382.0% | -1743.0% | · | |
| Net Margin | -277.5% | -1613.9% | · | |
| Pretax Margin | -363.2% | -1721.7% | · | |
| EBITDA Margin | -382.0% | -1743.0% | · | |
| ROA | -13.8% | -58.8% | · | |
| ROE | -16.7% | -79.6% | · | |
| ROIC | -16.7% | -82.0% | · |
Płynność i wypłacalność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 12.0 | 10.7 | · | |
| Quick Ratio | 3.4 | 3.0 | · |
Efektywność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | |
| Receivables Turnover | 7.6 | 6.7 | · |
Stopy Wzrostu 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 17.2% | 34.9% | 67.6% | |
| Revenue CAGR 3Y | 38.4% | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $147M | $126M | · | |
| Net Income TTM | $-408M | $-2.03B | · | |
| Market Cap | $3.45B | $605M | · | |
| P/E | -7.7 | -0.3 | · | |
| P/S | 23.5 | 4.8 | · | |
| P/B | 1.3 | 0.2 | · | |
| P / Tangible Book | 4.7 | 1.2 | · | |
| P / Cash Flow | -11.5 | -1.0 | · | |
| P / FCF | -11.5 | -1.0 | · | |
| Earnings Yield | -13.0% | -356.0% | · |
Rachunek zysków i strat 15
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45M | $41M | $44M | $36M | $36M | $32M | $38M | $29M | $32M | $27M | $30M | $21M | |
| R&D Expense | $47M | $48M | $47M | $49M | $47M | $54M | $48M | $78M | $94M | $102M | · | · | |
| SG&A Expense | $51M | $43M | $39M | $37M | $38M | $45M | $42M | $47M | $67M | $57M | · | · | |
| Operating Expenses | $218M | $177M | $168M | $161M | $194M | $185M | $175M | $212M | $1.67B | $254M | $225M | $933M | |
| Operating Income | $-174M | $-136M | $-124M | $-125M | $-159M | $-154M | $-137M | $-184M | $-1.64B | $-227M | $-195M | $-912M | |
| Interest Income | $7M | $8M | $8M | $6M | $7M | $8M | $9M | $12M | $3M | $3M | $1M | $3M | |
| Other Non-op | $-155.0K | $256.0K | $-64.0K | $466.0K | $-811.0K | $-584.0K | $578.0K | $-561.0K | $5.0K | $42.0K | $213.0K | $-196.0K | |
| Pretax Income | $-167M | $-128M | $-117M | $-119M | $-153M | $-146M | $-127M | $-172M | $-1.64B | $-224M | $-193M | $-910M | |
| Income Tax | $-56M | $-34M | $-17M | $-30M | $-39M | $-40M | $-30M | $-47M | $-53M | $-6M | $-6M | $-19M | |
| Net Income | $-110M | $-93M | $-99M | $-89M | $-114M | $-106M | $-97M | $-126M | $-1.59B | $-219M | $-885M | $-891M | |
| EPS (Basic) | $-2.56 | $-2.29 | $-2.37 | $-2.46 | $-3.18 | $-3.10 | $-1.49 | $-3.94 | $-51.06 | $-7.05 | $-6.04 | $-28.71 | |
| EPS (Diluted) | $-2.56 | $-2.29 | $-2.37 | $-2.46 | $-3.18 | $-3.10 | $-1.49 | $-3.94 | $-51.06 | $-7.05 | $-6.04 | $-28.71 | |
| Shares (Basic) | 43,112,595 | 40,640,879 | -69,472,094 | 36,124,256 | 35,793,154 | 34,308,435 | -62,077,091 | 31,880,054 | 31,049,148 | 31,049,148 | 0 | 0 | |
| Shares (Diluted) | 43,112,595 | 40,640,879 | -69,472,094 | 36,124,256 | 35,793,154 | 34,308,435 | -62,077,091 | 31,880,054 | 31,049,148 | 31,049,148 | 0 | 0 | |
| EBITDA | $-174M | $-136M | · | $-125M | $-159M | $-154M | · | $-184M | $-1.64B | · | · | · |
Bilans 25
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $56M | $69M | $250M | $127M | $127M | $134M | $214M | $854M | $959M | · | $97M | · | |
| Receivables | $20M | $20M | $18M | $16M | $16M | $19M | $20M | · | · | · | · | · | |
| Prepaid Expense | $16M | $17M | $15M | $15M | $13M | $15M | $17M | $20M | $21M | · | · | · | |
| Current Assets | $915M | $877M | $954M | $589M | $652M | $728M | $820M | $910M | $1.02B | · | · | · | |
| PP&E (Net) | $44M | $48M | $52M | $56M | $60M | $65M | $69M | · | · | · | · | · | |
| PP&E (Gross) | · | · | $122M | · | · | · | $123M | · | · | · | · | · | |
| Accum. Depreciation | · | · | $70M | · | · | · | $54M | · | · | · | · | · | |
| Goodwill | · | · | · | · | · | · | $0 | $0 | $0 | · | $889M | · | |
| Intangibles | $1.78B | $1.82B | $1.85B | $1.89B | $1.92B | $1.98B | $2.02B | $2.05B | $2.09B | · | · | · | |
| Other Non-current Assets | $7M | $7M | $7M | $7M | $7M | $7M | $8M | $8M | $8M | · | · | · | |
| Total Assets | $2.84B | $2.80B | $2.92B | $2.60B | $2.70B | $2.85B | $2.98B | $3.12B | $3.27B | · | · | · | |
| Accounts Payable | $7M | $5M | $2M | $3M | $6M | $6M | $5M | · | · | · | · | · | |
| Accrued Liabilities | $64M | $58M | $64M | $58M | $49M | $54M | $57M | $69M | $57M | · | · | · | |
| Current Liabilities | $84M | $75M | $80M | $77M | $71M | $75M | $77M | $94M | $88M | · | · | · | |
| Capital Leases | $81M | $41M | $43M | $45M | $48M | $51M | $55M | $59M | $62M | · | · | · | |
| Deferred Tax | $134M | $184M | $219M | $236M | $266M | $305M | $346M | $375M | $422M | · | · | · | |
| Other Non-current Liabilities | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | · | · | · | |
| Total Liabilities | $301M | $303M | $344M | $361M | $388M | $434M | $480M | $530M | $575M | · | · | · | |
| Common Stock | $45.0K | $41.0K | $40.0K | $36.0K | $36.0K | $35.0K | $34.0K | $33.0K | $31.0K | · | · | · | |
| Paid-in Capital | $12.96B | $12.80B | $12.79B | $12.35B | $12.34B | $12.32B | $12.31B | $12.29B | $12.27B | · | · | · | |
| Retained Earnings | $-10.42B | $-10.30B | $-10.21B | $-10.11B | $-10.02B | $-9.91B | $-9.80B | $-9.71B | $-9.58B | · | · | · | |
| AOCI | $2M | $2M | $3M | $2M | $2M | $2M | $1M | $2M | $1M | · | · | · | |
| Stockholders' Equity | $2.54B | $2.50B | $2.58B | $2.24B | $2.31B | $2.41B | $2.50B | $2.59B | $2.70B | · | · | · | |
| Liabilities + Equity | $2.84B | $2.80B | $2.92B | $2.60B | $2.70B | $2.85B | $2.98B | $3.12B | $3.27B | · | · | · | |
| Shares Outstanding | 44,666,234 | 41,134,219 | 40,331,360 | 36,160,998 | 36,047,799 | 35,296,858 | 33,893,409 | 33,203,744 | 31,049,148 | · | 0 | · |
Przepływy pieniężne 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $20M | $17M | $14M | $14M | $14M | $16M | $14M | $17M | $26M | $29M | $25M | $25M | |
| Deferred Tax | $-57M | $-35M | $-17M | $-30M | $-39M | $-40M | $-29M | $-47M | $-53M | $-5M | $-4M | $-18M | |
| Amort. of Intangibles | $33M | $33M | $30M | $35M | $33M | $33M | $30M | $35M | $35M | $35M | $30M | $35M | |
| Restructuring | · | · | · | · | · | · | · | $19M | · | · | · | · | |
| Operating Cash Flow | $-81M | $-87M | $-64M | $-63M | $-77M | $-95M | $-93M | $-105M | $-172M | $-207M | $-129M | $-158M | |
| CapEx | $432.0K | $503.0K | $94.0K | $384.0K | $369.0K | $62.0K | $303.0K | $971.0K | $1M | $3M | · | · | |
| Investing Cash Flow | $-47M | $-93M | $-237M | $67M | $70M | $15M | $-546M | $-971.0K | $-1M | $-3M | $-4M | $-3M | |
| Financing Cash Flow | · | · | $423M | $0 | $0 | $0 | $0 | $0 | $932M | $312M | $86M | $74M | |
| Net Change in Cash | $-14M | $-180M | $123M | $3M | $-6M | $-80M | $-640M | $-105M | $759M | $102M | $-47M | $-87M | |
| Free Cash Flow | · | $-87M | · | · | · | $-95M | · | · | · | · | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -388.9% | -332.9% | · | -346.2% | -446.9% | -482.5% | · | -640.5% | -5133.9% | · | · | · | |
| Net Margin | -246.7% | -228.5% | · | -245.8% | -320.7% | -333.6% | · | -438.7% | -4958.8% | · | · | · | |
| Pretax Margin | -373.1% | -312.7% | · | -328.0% | -430.1% | -459.9% | · | -601.7% | -5125.1% | · | · | · | |
| EBITDA Margin | -388.9% | -332.9% | · | -346.2% | -446.9% | -482.5% | · | -640.5% | -5133.9% | · | · | · | |
| ROA | -4.0% | -3.3% | · | -3.1% | -3.8% | -7.5% | · | -8.1% | -97.0% | · | · | · | |
| ROE | -4.5% | -3.8% | · | -3.7% | -4.5% | -8.8% | · | -9.7% | -117.6% | · | · | · | |
| ROIC | -4.5% | -4.0% | · | -4.2% | -5.1% | -4.6% | · | -5.2% | -58.9% | · | · | · |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.9 | 11.7 | · | 7.6 | 9.2 | 9.7 | · | 9.7 | 11.6 | · | · | · | |
| Quick Ratio | 0.9 | 1.2 | · | 1.8 | 2.0 | 2.0 | · | 9.1 | 10.9 | · | · | · |
Efektywność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | |
| Receivables Turnover | 2.5 | 2.1 | · | 4.4 | 4.4 | 3.3 | · | · | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $157M | $144M | · | $132M | $128M | $119M | · | $108M | $102M | · | · | · | |
| Net Income TTM | $-406M | $-402M | · | $-435M | $-1.93B | $-2.04B | · | $-2.82B | $-2.89B | · | · | · | |
| Market Cap | $3.05B | $2.13B | · | $2.14B | $1.85B | $901M | · | $457M | $477M | · | · | · | |
| P/E | -6.5 | -4.7 | · | -4.7 | -0.8 | -0.4 | · | -0.2 | -0.2 | · | · | · | |
| P/S | 19.4 | 14.7 | · | 16.2 | 14.5 | 7.6 | · | 4.2 | 4.7 | · | · | · | |
| P/B | 1.2 | 0.9 | · | 1.0 | 0.8 | 0.4 | · | 0.2 | 0.2 | · | · | · | |
| P / Tangible Book | 4.0 | 3.1 | · | 6.0 | 4.7 | 2.1 | · | 0.9 | 0.8 | · | · | · | |
| P / Cash Flow | · | -24.4 | · | · | · | -9.5 | · | · | · | · | · | · | |
| P / FCF | · | -24.3 | · | · | · | -9.5 | · | · | · | · | · | · | |
| Earnings Yield | -15.4% | -21.3% | · | -21.4% | -119.2% | -255.1% | · | -659.6% | -605.3% | · | · | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-01-01 | |
|---|---|---|---|---|
| Przychody | $147M | $126M | $93M | $56M |
| Marża Operacyjna % | -382.0% | -1743.0% | — | — |
| Zysk netto | $-408M | $-2.03B | $-1.47B | $-5.40B |
| Rozwodniony EPS | $-11.11 | $-63.54 | $-47.21 | $-173.89 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-01-01 | |
|---|---|---|---|---|
| Wskaźnik bieżący | 12.0 | 10.7 | — | — |
| Wskaźnik Szybkości | 3.4 | 3.0 | — | — |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-01-01 | |
|---|---|---|---|---|
| Wolny przepływ pieniężny | $-300M | $-582M | — | — |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
- Is Grail (GRAL) Stock a Buy, Sell, or Hold at Under $70?
- Oto dlaczego akcje Grail znacznie wzrosły w tym tygodniu
- Ten Inwestor Sprzedał Udziały o Wartości 22 Milionów Dolarów w GRAIL Przed 50% Spadkiem Kursu Akcji w Jednym Dniu W Ubiegłym Miesiącu
- Here's Why Grail Shares Crushed the Market This Week
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 413 emitentów · $2.2B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 61 (+3 vs poprzedni kw.) | 46 (-47 vs poprzedni kw.) | 110 (+12 vs poprzedni kw.) | 103 (-12 vs poprzedni kw.) | +4.6M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $284 111 340 | 4 161 584 | 13,20% | Akcje |
| BAKER BROS. ADVISORS LP | $275 033 478 | 4 028 614 | 12,77% | Akcje |
| STATE STREET CORP | $162 859 041 | 2 385 514 | 7,56% | Akcje |
| PRIMECAP MANAGEMENT CO/CA/ | $148 835 838 | 2 180 106 | 6,91% | Akcje |
| Sessa Capital IM, L.P. | $139 101 354 | 2 037 518 | 6,46% | Akcje |
| Deep Track Capital, LP | $125 271 627 | 1 834 944 | 5,82% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $112 039 058 | 1 641 117 | 5,20% | Akcje |
| Arbiter Partners Capital Management LLC | $70 611 456 | 1 034 297 | 3,28% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $58 460 697 | 856 182 | 2,72% | Akcje |
| Jefferies Financial Group Inc. | $49 427 480 | 724 000 | 2,30% | Akcje |
| Jefferies Financial Group Inc. | $44 375 500 | 650 000 | 2,06% | Opcja sprzedaży |
| DIMENSIONAL FUND ADVISORS LP | $43 707 751 | 640 219 | 2,03% | Akcje |
| GOLDMAN SACHS GROUP INC | $42 579 111 | 623 687 | 1,98% | Akcje |
| BANK OF AMERICA CORP /DE/ | $42 152 219 | 617 434 | 1,96% | Akcje |
| Casdin Capital, LLC | $32 769 600 | 480 000 | 1,52% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $32 631 831 | 477 982 | 1,52% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $25 396 440 | 372 000 | 1,18% | Opcja kupna |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $24 563 546 | 359 800 | 1,14% | Opcja sprzedaży |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | $23 211 800 | 340 000 | 1,08% | Akcje |
| Granahan Investment Management, LLC | $21 926 686 | 321 176 | 1,02% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $20 523 874 | 300 628 | 0,95% | Akcje |
| Aberdeen Group plc | $15 668 170 | 229 503 | 0,73% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $15 357 337 | 224 950 | 0,71% | Akcje |
| Slow Capital, Inc. | $14 832 477 | 217 262 | 0,69% | Akcje |
| CITADEL ADVISORS LLC | $14 616 607 | 214 100 | 0,68% | Opcja kupna |
| TCW GROUP INC | $13 101 901 | 191 913 | 0,61% | Akcje |
| Douglas Lane & Associates, LLC | $11 082 952 | 162 340 | 0,51% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $10 601 990 | 155 295 | 0,49% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $10 495 215 | 153 731 | 0,49% | Akcje |
| Newtyn Management, LLC | $10 240 500 | 150 000 | 0,48% | Akcje |
| 180 WEALTH ADVISORS, LLC | $8 723 113 | 127 774 | 0,41% | Akcje |
| Voleon Capital Management LP | $8 264 903 | 121 062 | 0,38% | Akcje |
| FMR LLC | $8 139 559 | 119 226 | 0,38% | Akcje |
| WIM INVESTMENT MANAGEMENT Ltd | $7 263 928 | 106 400 | 0,34% | Akcje |
| Alyeska Investment Group, L.P. | $7 168 350 | 105 000 | 0,33% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $6 774 228 | 99 227 | 0,31% | Akcje |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $5 809 000 | 85 089 | 0,27% | Akcje |
| Swiss National Bank | $5 202 174 | 76 200 | 0,24% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $4 853 178 | 71 088 | 0,23% | Akcje |
| NATIXIS | $4 794 329 | 70 226 | 0,22% | Akcje |
| CITADEL ADVISORS LLC | $4 601 398 | 67 400 | 0,21% | Opcja sprzedaży |
| BARCLAYS PLC | $4 557 091 | 66 751 | 0,21% | Akcje |
| GAMCO INVESTORS, INC. ET AL | $4 554 497 | 66 713 | 0,21% | Akcje |
| D. E. Shaw & Co., Inc. | $4 444 787 | 65 106 | 0,21% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3 810 968 | 55 822 | 0,18% | Akcje |
| Allianz Asset Management GmbH | $3 810 695 | 55 818 | 0,18% | Akcje |
| JANE STREET GROUP, LLC | $3 775 331 | 55 300 | 0,18% | Opcja kupna |
| RHUMBLINE ADVISERS | $3 773 202 | 55 269 | 0,18% | Akcje |
| Public Sector Pension Investment Board | $3 633 534 | 53 223 | 0,17% | Akcje |
| Pictet Asset Management Holding SA | $3 421 492 | 50 039 | 0,16% | Akcje |
| Centiva Capital, LP | $3 413 500 | 50 000 | 0,16% | Opcja kupna |
| Verition Fund Management LLC | $3 334 921 | 48 849 | 0,15% | Akcje |
| BlackRock, Inc. | $3 131 886 | 45 875 | 0,15% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $3 072 150 | 450 | 0,14% | Opcja kupna |
| D. E. Shaw & Co., Inc. | $3 072 150 | 45 000 | 0,14% | Opcja sprzedaży |
| Legal Advantage Investments, Inc. | $3 046 549 | 44 625 | 0,14% | Akcje |
| HighTower Advisors, LLC | $2 769 342 | 40 565 | 0,13% | Akcje |
| Rafferty Asset Management, LLC | $2 697 962 | 39 519 | 0,13% | Akcje |
| Timelo Investment Management Inc. | $2 662 530 | 39 000 | 0,12% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $2 492 320 | 48 226 | 0,12% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2 298 210 | 44 470 | 0,11% | Akcje |
| Lido Advisors, LLC | $2 270 250 | 33 254 | 0,11% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $2 252 910 | 330 | 0,10% | Opcja sprzedaży |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $2 211 768 | 30 719 | 0,10% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $2 133 984 | 31 258 | 0,10% | Akcje |
| Summit Financial, LLC | $2 103 877 | 30 817 | 0,10% | Akcje |
| GABELLI FUNDS LLC | $2 067 420 | 30 283 | 0,10% | Akcje |
| JONES FINANCIAL COMPANIES LLLP | $1 988 740 | 30 169 | 0,09% | Akcje |
| OSAIC HOLDINGS, INC. | $1 906 981 | 27 934 | 0,09% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $1 872 305 | 27 425 | 0,09% | Akcje |
| COMMERCE BANK | $1 841 993 | 26 981 | 0,09% | Akcje |
| UBS Group AG | $1 835 234 | 26 882 | 0,09% | Akcje |
| Concurrent Investment Advisors, LLC | $1 833 850 | 26 862 | 0,09% | Akcje |
| Gem Investment Advisors, LLC | $1 828 339 | 26 781 | 0,08% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $1 823 765 | 26 714 | 0,08% | Akcje |
| Legato Capital Management LLC | $1 804 649 | 26 434 | 0,08% | Akcje |
| PVG ASSET MANAGEMENT CORP | $1 767 305 | 25 887 | 0,08% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $1 761 366 | 25 800 | 0,08% | Akcje |
| IMC-Chicago, LLC | $1 710 368 | 25 053 | 0,08% | Akcje |
| Jackson Hole Capital Partners, LLC | $1 705 440 | 33 000 | 0,08% | Akcje |
| Sheets Smith Investment Management | $1 688 635 | 28 558 | 0,08% | Akcje |
| MetLife Investment Management, LLC | $1 649 813 | 24 166 | 0,08% | Akcje |
| Gotham Asset Management, LLC | $1 634 384 | 23 940 | 0,08% | Akcje |
| Quantinno Capital Management LP | $1 593 922 | 23 347 | 0,07% | Akcje |
| TWO SIGMA ADVISERS, LP | $1 592 060 | 18 601 | 0,07% | Akcje |
| CLOUGH CAPITAL PARTNERS L P | $1 566 387 | 22 944 | 0,07% | Akcje |
| STATE OF WISCONSIN INVESTMENT BOARD | $1 522 353 | 22 299 | 0,07% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1 474 427 | 21 597 | 0,07% | Akcje |
| LPL Financial LLC | $1 393 254 | 20 408 | 0,06% | Akcje |
| PROFUND ADVISORS LLC | $1 370 725 | 20 078 | 0,06% | Akcje |
| Perigon Wealth Management, LLC | $1 348 537 | 19 753 | 0,06% | Akcje |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $1 271 324 | 18 622 | 0,06% | Akcje |
| Invesco Ltd. | $1 117 853 | 16 374 | 0,05% | Akcje |
| Bouvel Investment Partners, LLC | $1 106 998 | 16 215 | 0,05% | Akcje |
| AMERIPRISE FINANCIAL INC | $1 082 216 | 15 852 | 0,05% | Akcje |
| NORGES BANK | $1 077 983 | 15 790 | 0,05% | Akcje |
| EXCHANGE TRADED CONCEPTS, LLC | $1 054 703 | 15 449 | 0,05% | Akcje |
| STRS OHIO | $1 044 531 | 15 300 | 0,05% | Akcje |
| PRUDENTIAL FINANCIAL INC | $1 006 300 | 14 740 | 0,05% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $996 469 | 14 596 | 0,05% | Akcje |
Insiderzy spółki 8 insiderów · 2 dyrektorzy generalni · 5 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Joshua J. Ofman | Chief Executive Officer | 1 czerwca 2026 A | 402 271 | 0 | 0 | $0 |
| Andrew John Partridge | Chief Growth Officer | 4 czerwca 2026 S | 163 738 | 0 | 1 | $-91 070 |
| William J Chase | Dyrektor | 15 lipca 2026 A | 42 978 | 0 | 0 | $0 |
| Steven Mizell | Dyrektor | 15 lipca 2026 A | 42 830 | 0 | 0 | $0 |
| Gregory L Summe | Dyrektor | 15 lipca 2026 A | 45 672 | 0 | 0 | $0 |
| Sarah Krevans | Dyrektor | 18 czerwca 2026 A | 42 628 | 0 | 0 | $0 |
| ILLUMINA, INC. | Posiadacz 10% | 17 listopada 2025 S | 3 502 126 | 0 | 1 | $-79 850 000 |
| Chun R Ding | Posiadacz 10% | 9 października 2024 P | 3 644 855 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 51 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,90% | 18 597 NS | 30 kwietnia 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,63% | 59 651 NS | 30 kwietnia 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,22% | 87 328 SH | 19 sierpnia 2026 | Dziennie |
| IBB · iShares Trust | 0,21% | 294 889 SH | 19 sierpnia 2026 | Dziennie |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,20% | 2 376 SH | 19 sierpnia 2026 | Dziennie |
| IWN · iShares Trust | 0,19% | 387 025 SH | 19 sierpnia 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,18% | 36 116 SH | 19 sierpnia 2026 | Dziennie |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,17% | 67 501 NS | 31 maja 2026 | N-PORT |
| ESSC · Strategy Shares | 0,15% | 712 NS | 30 kwietnia 2026 | N-PORT |
| BIB · ProShares Trust | 0,14% | 1 439 NS | 31 maja 2026 | N-PORT |
| PSC · Principal Exchange-Traded Funds | 0,12% | 41 189 NS | 30 czerwca 2026 | N-PORT |
| IWM · iShares Trust | 0,09% | 1 063 187 SH | 19 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,09% | 237 749 SH | 19 sierpnia 2026 | Dziennie |
| GSSC · Goldman Sachs ETF Trust | 0,08% | 11 051 NS | 31 maja 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,08% | 1 185 NS | 30 kwietnia 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 9 665 NS | 30 kwietnia 2026 | N-PORT |
| ITWO · ProShares Trust | 0,06% | 1 654 NS | 31 maja 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,06% | 2 459 SH | 19 sierpnia 2026 | Dziennie |
| RSSL · Global X Funds | 0,06% | 15 208 NS | 30 kwietnia 2026 | N-PORT |
| ESML · iShares Trust | 0,05% | 22 013 SH | 19 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,05% | 117 357 NS | 30 kwietnia 2026 | N-PORT |
| ISCG · iShares Trust | 0,05% | 6 428 SH | 19 sierpnia 2026 | Dziennie |
| SCHA · SCHWAB STRATEGIC TRUST | 0,05% | 143 168 NS | 31 maja 2026 | N-PORT |
| ISCB · iShares Trust | 0,04% | 1 731 SH | 19 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,04% | 114 187 SH | 19 sierpnia 2026 | Dziennie |
| ISCV · iShares Trust | 0,04% | 3 927 SH | 19 sierpnia 2026 | Dziennie |
| UWM · ProShares Trust | 0,04% | 1 294 NS | 31 maja 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 16 096 NS | 30 kwietnia 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 374 291 SH | 19 sierpnia 2026 | Dziennie |
| URTY · ProShares Trust | 0,03% | 1 307 NS | 31 maja 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 2 078 SH | 19 sierpnia 2026 | Dziennie |
| DXUV · Dimensional ETF Trust | 0,02% | 1 178 NS | 30 kwietnia 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 1 399 NS | 31 maja 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,01% | 23 351 NS | 31 maja 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 33 NS | 31 maja 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 4 910 NS | 30 kwietnia 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 11 015 NS | 31 maja 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 51 657 NS | 30 kwietnia 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 11 743 SH | 19 sierpnia 2026 | Dziennie |
| IETC · iShares U.S. ETF Trust | 0,00% | 372 SH | 19 sierpnia 2026 | Dziennie |
| ITOT · iShares Trust | 0,00% | 45 901 SH | 19 sierpnia 2026 | Dziennie |
| ACVF · ETF Opportunities Trust | 0,00% | 82 NS | 30 kwietnia 2026 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,00% | 192 NS | 31 maja 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 17 955 NS | 31 maja 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 9 362 NS | 30 kwietnia 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 4 660 NS | 30 kwietnia 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,00% | 3 550 NS | 30 kwietnia 2026 | N-PORT |
| DFLV · Dimensional ETF Trust | 0,00% | 321 NS | 30 kwietnia 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 228 926 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 407 SH | 19 sierpnia 2026 | Dziennie |